Study | Duration (years) | Reference | Active | Placebo | No randomised |
---|---|---|---|---|---|
EUROSCOP | 3 | Pauwels et al1 | 27% | 30% | 1277 |
ISOLDE | 3 | Burge et al3 | 43% | 53% | 751 |
Copenhagen | 3 | Vestbo et al2 | 25% | 35% | 290 |
City Lung Study | |||||
LHS II | 3 | LHS Group4 | Not reported | Not reported | 1116 |
TRISTAN | 1 | Calverley et al8 | 29% | 38% | 1465 |
Symbicort | 1 | Szafranski et al7 | 30% | 44% | 812 |
1 | Calverley et al8 | 37% | 41% | 1022 | |
Tiotropium | 1 | Vincken et al5 | 15% | 21% | 535 |
1 | Casaburi et al6 | 19% | 28% | 921 | |
BRONCUS | 3 | Decramer et al33 | 27% | 37% | 573 |
Average | 27% | 37% |